logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Miltenyi Biotec Acquires Biosensor Company Lino Biotech

Mar 15, 2023•almost 3 years ago

Acquiring Company

Miltenyi Biotec B.V. & Co.KG

Acquired Company

lino Biotech AG

GeneticsBiotechnologyHealth CareBiotechnology

Description

lino Biotech, a leading biosensor company and the world's only provider of Focal Molography, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023.

Company Information

Company

Miltenyi Biotec B.V. & Co.KG

About

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health. Press Contact:Wordstatt GmbH info@wordstatt.de+49-172-8312173 SOURCE lino Biotech AG

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed